IE54119B1 - Pharmaceutical formulations comprising human insulin and human c-peptide - Google Patents

Pharmaceutical formulations comprising human insulin and human c-peptide

Info

Publication number
IE54119B1
IE54119B1 IE2064/82A IE206482A IE54119B1 IE 54119 B1 IE54119 B1 IE 54119B1 IE 2064/82 A IE2064/82 A IE 2064/82A IE 206482 A IE206482 A IE 206482A IE 54119 B1 IE54119 B1 IE 54119B1
Authority
IE
Ireland
Prior art keywords
human
insulin
peptide
human insulin
composition
Prior art date
Application number
IE2064/82A
Other languages
English (en)
Other versions
IE822064L (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IE822064L publication Critical patent/IE822064L/xx
Publication of IE54119B1 publication Critical patent/IE54119B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IE2064/82A 1981-08-27 1982-08-26 Pharmaceutical formulations comprising human insulin and human c-peptide IE54119B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (2)

Publication Number Publication Date
IE822064L IE822064L (en) 1983-02-27
IE54119B1 true IE54119B1 (en) 1989-06-21

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2064/82A IE54119B1 (en) 1981-08-27 1982-08-26 Pharmaceutical formulations comprising human insulin and human c-peptide

Country Status (20)

Country Link
JP (1) JPS5846024A (de)
AU (1) AU551879B2 (de)
BE (1) BE894185A (de)
CA (1) CA1176158A (de)
CH (1) CH650679A5 (de)
DE (1) DE3232034A1 (de)
DZ (1) DZ452A1 (de)
FR (1) FR2513126B1 (de)
GB (1) GB2104382B (de)
IE (1) IE54119B1 (de)
IL (1) IL66611A0 (de)
IT (1) IT1153182B (de)
LU (1) LU84359A1 (de)
MW (1) MW3882A1 (de)
NL (1) NL192192C (de)
NZ (1) NZ201682A (de)
PH (1) PH19361A (de)
SE (1) SE460334B (de)
ZA (1) ZA826159B (de)
ZW (1) ZW17482A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
AU8175387A (en) * 1986-10-20 1988-05-06 Novo Industri A/S Protamine zinc insulin preparations
IE62879B1 (en) * 1987-02-25 1995-03-08 Novo Nordisk As Novel insulin derivatives
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
EP0303308B1 (de) * 1987-08-14 1991-05-29 Akzo N.V. Präparat zur Verhütung oder Bekämpfung von Komplikationen bei Diabetes
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
CN101060856B (zh) * 2004-11-22 2011-01-19 诺和诺德公司 可溶、稳定的含胰岛素制剂
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
WO2010033207A1 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of therapeutic peptides
KR20130115086A (ko) * 2010-05-17 2013-10-21 세빅스 인코포레이티드 페길화된 c-펩티드
CN104220086A (zh) 2011-11-17 2014-12-17 塞比克斯股份公司 Peg化的c-肽

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Also Published As

Publication number Publication date
NL192192C (nl) 1997-03-04
GB2104382B (en) 1984-12-19
ZA826159B (en) 1984-04-25
NL192192B (nl) 1996-11-01
AU551879B2 (en) 1986-05-15
DE3232034C2 (de) 1991-04-11
IT1153182B (it) 1987-01-14
IL66611A0 (en) 1982-12-31
AU8759482A (en) 1983-03-03
NZ201682A (en) 1985-08-16
SE460334B (sv) 1989-10-02
SE8204873D0 (sv) 1982-08-25
JPS5846024A (ja) 1983-03-17
DZ452A1 (fr) 2004-09-13
MW3882A1 (en) 1984-07-11
FR2513126B1 (fr) 1986-04-18
GB2104382A (en) 1983-03-09
IE822064L (en) 1983-02-27
IT8223017A0 (it) 1982-08-27
DE3232034A1 (de) 1983-03-10
CH650679A5 (de) 1985-08-15
NL8203315A (nl) 1983-03-16
PH19361A (en) 1986-04-02
BE894185A (fr) 1983-02-24
FR2513126A1 (fr) 1983-03-25
ZW17482A1 (en) 1982-11-17
CA1176158A (en) 1984-10-16
LU84359A1 (fr) 1983-02-28
SE8204873L (sv) 1983-02-28

Similar Documents

Publication Publication Date Title
KR100546225B1 (ko) 신속한 작용개시를 나타내는 인슐린 유도체
CA1176161A (en) Pharmaceutical formulations comprising human insulin and human proinsulin
US6136784A (en) Amylin agonist pharmaceutical compositions containing insulin
KR100386038B1 (ko) 단량체성인슐린유사체의제제
US4608364A (en) Pharmaceutical agent for the treatment of diabetes mellitus
CA1176158A (en) Pharmaceutical formulations comprising human insulin and human c-peptide
US4652548A (en) Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
AU642665B2 (en) Treatment of insulin-resistant diabetes
JPWO2004037859A1 (ja) Glp−1誘導体及びその経粘膜吸収型製剤
EP0613376B1 (de) Verwendung von igf-1
CA2527039C (en) Grf analog compositions and their use
US4654324A (en) Human proinsulin pharmaceutical formulations
JP4726797B2 (ja) 消耗症に罹患している患者の治療における成長ホルモン放出因子類似体の使用
JP4402296B2 (ja) 亜鉛結合性が増大された新規なインスリン同族体
CA1176160A (en) Human proinsulin pharmaceutical formulations
CA1176159A (en) Pharmaceutical formulations comprising human insulin, human c-peptide, and human proinsulin
AU2004283526A1 (en) Therapeutic applications for C-peptide
AU5916298A (en) Amylin agonist pharmaceutical compositions containing insulin

Legal Events

Date Code Title Description
MK9A Patent expired